News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
483,342 Results
Type
Article (8084)
Company Profile (140)
Press Release (475118)
Multimedia
Podcasts (5)
Webinars (6)
Section
Business (166890)
Career Advice (304)
Deals (25766)
Drug Delivery (7)
Drug Development (52903)
Employer Resources (14)
FDA (9761)
Job Trends (8573)
News (238345)
Policy (17903)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (485)
Accelerated approval (21)
ADA (18)
Adcomms (1)
Allergies (94)
Alliances (33211)
ALS (102)
Alzheimer's disease (965)
Antibody-drug conjugate (ADC) (253)
Approvals (10330)
Artificial intelligence (308)
ASCO (160)
Autoimmune disease (194)
Automation (27)
Bankruptcy (262)
Best Places to Work (6959)
BIO (36)
BIOSECURE Act (1)
Biosimilars (103)
Biotechnology (89)
Bladder cancer (132)
Brain cancer (28)
Breast cancer (498)
Cancer (3546)
Cardiovascular disease (213)
Career advice (245)
Career pathing (1)
CAR-T (167)
Celiac Disease (1)
Cell therapy (464)
Cervical cancer (34)
Clinical research (47731)
Collaboration (1197)
Compensation (1384)
Complete response letters (33)
COVID-19 (754)
CRISPR (62)
C-suite (701)
Cystic fibrosis (84)
Data (5488)
Denatured (4)
Depression (101)
Dermatology (59)
Diabetes (332)
Diagnostics (4158)
Digital health (36)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (144)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (157)
Earnings (73002)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87475)
Executive appointments (677)
FDA (12268)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (16)
Frontotemporal dementia (23)
Funding (888)
Gene editing (128)
Generative AI (9)
Gene therapy (311)
GLP-1 (285)
Government (942)
Grass and pollen (2)
Guidances (278)
Healthcare (9314)
Hematology (95)
HIV (49)
Huntington's disease (22)
IgA nephropathy (60)
Immunology and inflammation (95)
Immuno-oncology (54)
Indications (149)
Infectious disease (940)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (83)
Intellectual property (245)
Interviews (41)
IPO (12402)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (14)
Layoffs (61)
Legal (5195)
Liver cancer (43)
Longevity (15)
Lung cancer (487)
Lymphoma (240)
Machine learning (27)
Management (3)
Manufacturing (506)
Marketing (6)
MASH (115)
Medical device (8629)
Medtech (8745)
Mergers & acquisitions (14354)
Metabolic disorders (686)
mRNA (50)
Multiple sclerosis (101)
NASH (4)
Neurodegenerative disease (209)
Neuropsychiatric disorders (38)
Neuroscience (1776)
NextGen: Class of 2026 (3164)
Non-profit (843)
Obesity (220)
Opinion (10)
Ovarian cancer (155)
Pain (167)
Pancreatic cancer (190)
Parkinson's disease (195)
Partnered (11)
Patents (454)
Patient recruitment (473)
Peanut (31)
People (41140)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15434)
Phase 2 (21313)
Phase 3 (14347)
Pipeline (6605)
Policy (18)
Postmarket research (1570)
Preclinical (6530)
Press Release (34)
Prostate cancer (185)
Psychedelics (7)
Radiopharmaceuticals (187)
Rare diseases (551)
Real estate (3020)
Recruiting (6)
Regulatory (14657)
Reports (16)
Research institute (583)
Resumes & cover letters (45)
Rett syndrome (39)
RNA editing (5)
RSV (47)
Schizophrenia (97)
Series A (148)
Series B (116)
Service/supplier (4)
Sickle cell disease (61)
Spinal muscular atrophy (87)
Sponsored (5)
Startups (2029)
Stomach cancer (3)
Supply chain (47)
The Weekly (1)
Vaccines (312)
Venture capital (17)
Weight loss (69)
Women's health (74)
Date
Today (48)
Last 7 days (265)
Last 30 days (1062)
Last 365 days (19114)
2026 (10558)
2025 (19267)
2024 (23028)
2023 (26576)
2022 (34638)
2021 (37217)
2020 (33505)
2019 (23297)
2018 (17525)
2017 (18804)
2016 (17947)
2015 (24276)
2014 (21688)
2013 (18140)
2012 (20230)
2011 (20447)
2010 (20338)
Location
Africa (227)
Alabama (68)
Alaska (2)
Arizona (290)
Arkansas (11)
Asia (17858)
Australia (2100)
California (11466)
Canada (3037)
China (500)
Colorado (462)
Connecticut (388)
Delaware (201)
Europe (24673)
Florida (1708)
Georgia (363)
Hawaii (2)
Idaho (46)
Illinois (675)
India (40)
Indiana (308)
Iowa (13)
Japan (383)
Kansas (98)
Kentucky (30)
Louisiana (24)
Maine (25)
Maryland (1146)
Massachusetts (7562)
Michigan (299)
Minnesota (534)
Mississippi (4)
Missouri (76)
Montana (20)
Nebraska (11)
Nevada (112)
New Hampshire (60)
New Jersey (2527)
New Mexico (11)
New York (2724)
North Carolina (1223)
North Dakota (4)
Northern California (5699)
Ohio (263)
Oklahoma (14)
Oregon (16)
Pennsylvania (2184)
Puerto Rico (20)
Rhode Island (29)
South America (406)
South Carolina (75)
South Dakota (1)
Southern California (4756)
Tennessee (113)
Texas (1848)
United States (37324)
Utah (341)
Vermont (1)
Virginia (145)
Washington D.C. (38)
Washington State (891)
West Virginia (1)
Wisconsin (71)
483,342 Results for "metagenics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
HKG epiTherapeutics Limited Announces the Launch of its MetaGen Mutations Panel
HKG epiTherapeutics Limited announced today the launch of its new product, MetaGen Mutations Panel, an innovative genetic methylation test, which evaluates specific genes that offer individuals unparalleled insights into their genetic profiles and their effects on health and aging.
January 31, 2024
·
2 min read
Business
Metagenics Names Gavin Lindberg as CFO
Metagenics, Inc. (“Metagenics” or the “Company”), a leading global nutritional supplement company, today announced that it named Gavin J. Lindberg as Chief Financial Officer, effective January 17.
January 24, 2023
·
3 min read
Press Releases
Metagenomi Therapeutics, Inc. to Present at the 2026 Jefferies Global Healthcare Conference
May 28, 2026
·
1 min read
Biotech Bay
Metagenics Presents New Survey† Findings on Non-Hormonal Supplement for Menopause Symptom Relief at The Menopause Society’s Annual Meeting
Metagenics, LLC today announced results of a new patient survey evaluating the efficacy of Estrovera®, a nonhormonal supplement, for relieving common menopausal symptoms.
September 27, 2023
·
3 min read
Metagen Therapeutics Completes Series A Financing Raising a Total of 1.7 Billion Yen
Metagen Therapeutics, a company focusing on drug discovery and development based on intestinal microbiome-based therapeutics for various diseases, has completed its Series A funding in 2 rounds, raising a total of 1.7 billion yen.
June 15, 2023
·
7 min read
Press Releases
Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency
April 16, 2026
·
5 min read
Press Releases
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference
February 24, 2026
·
4 min read
Press Releases
Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook
January 13, 2026
·
7 min read
Biotech Beach
Metagenics Releases CardioLux™ HDL
Metagenics, Inc., a health sciences company, announced today the release of CardioLux HDL, the newest patent pending formula launched in the Metagenics product line.
February 6, 2020
·
2 min read
Press Releases
Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
May 11, 2026
·
7 min read
1 of 48,335
Next
